Citi Pharma Limited (PSX:CPHL)
Pakistan · Delayed Price · Currency is PKR 62.04
-1.46 (-2.30%)
At close: Oct 15, 2026
Citi Pharma Financials Overview
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 14,076 | 14,076 | 13,154 | 12,409 | 12,397 | 9,780 |
Revenue Growth | 7.01% | 7.01% | 6.00% | 0.10% | 26.76% | 68.75% |
Gross Profit Gross Profit Growth | 2,473 | 2,473 | 2,018 | 1,586 | 1,507 | 1,363 |
Operating Income Operating Income Growth | 1,940 | 1,940 | 1,604 | 1,206 | 1,167 | 993.48 |
Net Income Net Income Growth | 790.33 | 790.33 | 892.04 | 833.46 | 657.98 | 653.69 |
Earnings Per Share EPS Growth | 3.46 | 3.46 | 3.90 | 3.65 | 2.88 | 2.88 |
EPS Growth | -11.40% | -11.40% | 7.03% | 26.67% | 0% | 53.04% |
| Fiscal Year | TTM | FY 2026 | FY 2025 |
|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 |
Pakistan Pakistan Growth | 13,739 | 13,739 | 12,996 |
Unallocated Unallocated Growth | -138.75 | -138.75 | -211.45 |
Export Export Growth | 475.66 | 475.66 | 368.91 |
Total Total Growth | 14,076 | 14,076 | 13,154 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 348.24 | 348.24 | 1,590 | 1,418 | 1,580 | 2,000 |
Total Debt Total Debt Growth | 3,100 | 3,100 | 2,950 | 1,455 | 1,843 | 943.48 |
Net Cash (Debt) Net Cash Growth | -2,751 | -2,751 | -1,360 | -36.55 | -262.2 | 1,056 |
Net Cash Growth | - | - | - | - | - | -61.65% |
Net Cash Per Share Net Cash Per Share Growth | -12.04 | -12.04 | -5.95 | -0.16 | -1.15 | 4.66 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 162.06 | 162.06 | -320.7 | 1,338 | -329 | -322.97 |
Capital Expenditures CapEx Growth | -706.69 | -706.69 | -150.06 | -568.2 | -954.47 | -600.46 |
Free Cash Flow Free Cash Flow Growth | -544.63 | -544.63 | -470.77 | 769.4 | -1,283 | -923.43 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 17.57% | 17.57% | 15.34% | 12.78% | 12.16% | 13.94% |
Operating Margin | 13.79% | 13.79% | 12.20% | 9.72% | 9.42% | 10.16% |
Pretax Margin | 9.55% | 9.55% | 10.30% | 10.32% | 7.72% | 10.84% |
Profit Margin | 5.62% | 5.62% | 6.78% | 6.72% | 5.31% | 6.68% |
FCF Margin | -3.87% | -3.87% | -3.58% | 6.20% | -10.35% | -9.44% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 16, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
Dividend Per Share Dividend Per Share Growth | 3.500 | - | 3.500 | 3.250 | 2.500 |
Dividend Per Share Growth | 7.69% | - | 7.69% | 30.00% | - |
Dividend Yield | 5.64% | - | 4.17% | 11.40% | 11.71% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 16, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 17.93 | 22.51 | 21.51 | 7.81 | 7.41 | 11.41 |
Forward PE | - | 18.68 | 14.23 | 6.55 | 6.34 | - |
P/FCF Ratio | - | - | - | 8.46 | - | - |
PS Ratio | 1.01 | 1.26 | 1.46 | 0.53 | 0.39 | 0.76 |